Upcoming Investor Conferences
Argentx (NASDAQ: ARGX), a leader in immunology focused on enhancing the quality of life for those battling severe autoimmune conditions, is gearing up for a couple of prominent investor conferences this coming September. These events not only illustrate the company's commitment to innovation but also provide a platform for sharing insights and developments with interested investors.
Wells Fargo Healthcare Conference
The first of these events is the 2025 Wells Fargo Healthcare Conference, where the management team of argentx will engage in a constructive fireside chat on Thursday, September 4, 2025, at 8:00 a.m. ET. This venue will provide an opportunity to discuss both present initiatives and future aspirations in the realm of healthcare.
Morgan Stanley Global Healthcare Conference
Following that, argentx will participate in the Morgan Stanley 23rd Annual Global Healthcare Conference. This presentation is scheduled for Monday, September 8, 2025, at 7:00 a.m. ET. Such gatherings are pivotal for networking and for showcasing the innovations in biomedical research that argentx has been pioneering.
Live Streaming and Presentation Access
Investors who are unable to attend these events in person will have access to a live webcast through the Investors section of the argentx website. Following the events, replays of the presentations will be available for viewing on the website for approximately 30 days, ensuring that stakeholders can stay informed regarding the latest organizational updates.
About Argentx
Argentx is dedicated to transforming the treatment landscape for individuals suffering from serious autoimmune diseases. The company collaborates with distinguished researchers through its Immunology Innovation Program (IIP), aiming to translate groundbreaking immunology findings into a diverse portfolio of innovative antibody-based therapies. Argentx is notably working on the first clinically approved neonatal Fc receptor (FcRn) blocker and is exploring its vast potential in treating various severe autoimmune disorders.
Contact Information
For media inquiries, contact Ben Petok at bpetok@argenx.com. For investor relations, reach out to Alexandra Roy at aroy@argenx.com.
Frequently Asked Questions
What is the significance of the upcoming investor conferences for argentx?
These conferences are essential for argentx to showcase its research advancements and engage with the investment community.
When are the designated conferences occurring?
The Wells Fargo Healthcare Conference is on September 4, 2025, and the Morgan Stanley conference is on September 8, 2025.
How can I access the presentations?
Live webcasts of the presentations can be accessed through the argentx website, with replays available for 30 days post-event.
What areas of immune therapy does argentx focus on?
Argentx primarily targets serious autoimmune diseases with its innovative antibody-based therapies.
Who should be contacted for media inquiries regarding argentx?
Media inquiries should be directed to Ben Petok via email.